Medullary Infarct: Acute and Secondary Treatment
For acute medullary infarction, administer aspirin 160-325 mg immediately after excluding hemorrhage on neuroimaging, followed by dual antiplatelet therapy (aspirin 81 mg + clopidogrel 75 mg with loading doses of 160-325 mg aspirin and 300-600 mg clopidogrel) for 21-30 days if NIHSS ≤3-5, then transition to single antiplatelet therapy long-term with high-intensity statin therapy.
Acute Phase Management
Immediate Assessment and Thrombolysis Consideration
Medullary infarcts represent only 3.7% of all ischemic strokes but require urgent recognition 1. The challenge is that these strokes often present with non-specific symptoms (dizziness in 94.4%, ataxia in 84.3%) that can mimic benign conditions, leading to delayed diagnosis 1.
Thrombolysis eligibility: Intravenous alteplase (0.9 mg/kg, maximum 90 mg) should be administered within 4.5 hours of symptom onset if no contraindications exist, with 10% given as bolus over 1 minute and 90% infused over 60 minutes 2. However, only 2.7% of medullary stroke patients actually receive thrombolysis in real-world practice 1, likely due to diagnostic delays and mild initial presentations (73% present with NIHSS 1-4) 1.
Critical pitfall: Initial CT scans frequently miss medullary infarcts. MRI with diffusion-weighted imaging (DWI) is essential for diagnosis 1, 3. The "heart appearance" sign on DWI indicates bilateral medial medullary infarction 3.
Antiplatelet Therapy Initiation
For minor stroke (NIHSS ≤3) or high-risk TIA:
- Load with aspirin 160-325 mg AND clopidogrel 300-600 mg as soon as hemorrhage is excluded 4
- Continue dual antiplatelet therapy (DAPT): aspirin 81 mg daily + clopidogrel 75 mg daily for 21 days 4
- Initiate within 12-24 hours of symptom onset for maximum benefit 4
For mild-moderate stroke (NIHSS ≤5):
- Alternative regimen: aspirin 75-100 mg + ticagrelor 90 mg twice daily (with loading doses of aspirin 300-325 mg and ticagrelor 180 mg) for 30 days 4
For moderate-severe strokes:
- Single antiplatelet therapy only (aspirin 81-325 mg, clopidogrel 75 mg, or aspirin/dipyridamole 25/200 mg twice daily) 5
- DAPT beyond 21-30 days increases bleeding risk without additional benefit 5
Etiologic Workup
In medullary infarcts specifically:
- 40.7% have large vessel atherosclerotic disease 1
- 37.6% have small vessel disease 1
- 5.5% have arterial dissection 1
Essential investigations:
- High-resolution MRI to identify vertebral artery dissection, which can initially appear as atherothrombotic disease 6
- 48-hour Holter monitoring detected atrial fibrillation in only 1.85% of medullary stroke patients 1, but should still be performed given treatment implications
- Vascular imaging (CTA or MRA) to assess vertebrobasilar system
Secondary Prevention
Long-term Antiplatelet Therapy
After completing 21-30 days of DAPT, transition to single antiplatelet therapy indefinitely 4:
- Clopidogrel 75 mg daily (preferred)
- OR aspirin 81-325 mg daily
- OR aspirin/dipyridamole 25/200 mg twice daily
In real-world practice: 98.2% of medullary stroke patients receive antiplatelet therapy, with 68.5% on single antiplatelet and 29.6% on dual antiplatelet therapy 1.
Lipid Management
Start high-intensity statin therapy immediately and continue long-term 4:
- Target LDL-C <1.8 mmol/L (70 mg/dL) OR
- Reduce LDL-C by ≥50% if baseline is 1.8-3.5 mmol/L (70-135 mg/dL) 4
Blood Pressure Control
For patients with moderate-to-high grade intracranial atherosclerotic stenosis (50-99%):
- Target systolic blood pressure <140 mmHg 4
- This is particularly relevant given that 40.7% of medullary infarcts are due to large vessel disease 1
Physical Activity
Recommend at least moderate physical activity for secondary prevention 4.
Special Considerations
Vertebral Artery Dissection
If dissection is identified (5.5% of cases) 1:
- Antiplatelet therapy is appropriate 5
- Endovascular stenting and coiling may be considered for growing dissecting aneurysms 6
- Serial imaging to monitor for aneurysm formation
Bilateral Medial Medullary Infarction
This rare subtype carries higher risk:
- 25% develop early neurological deterioration 7
- 65% have poor 90-day outcomes 7
- Requires aggressive supportive care for respiratory failure and dysphagia 8
- Early physical therapy intervention is critical 8
Anatomical Subtype Implications
The dorsomedial subtype has the worst prognosis with 65% poor outcomes, while oblique lateral has only 16.7% poor outcomes 7. However, treatment algorithms remain the same regardless of anatomical location.
Outcome Expectations
- 47% of medullary stroke patients are discharged home with functional independence (mRS 0-2) 1
- At follow-up, 74% achieve functional independence 1
- Independent predictors of poor outcome include: higher admission NIHSS, older age, dysphagia, contralateral limb involvement, and large-artery atherosclerosis 7